Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung

被引:236
作者
Oh, Phil
Borgstrom, Per
Witkiewicz, Halina
Li, Yan
Borgstrom, Bengt J.
Chrastina, Adrian
Iwata, Koji
Zinn, Kurt R.
Baldwin, Richard
Testa, Jacqueline E.
Schnitzer, Jan E.
机构
[1] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
[2] Univ Calif Los Angeles, EE Dept, Los Angeles, CA 90095 USA
[3] Gamma Med Inc, Northridge, CA 91324 USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
关键词
D O I
10.1038/nbt1292
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
How effectively and quickly endothelial caveolae can transcytose in vivo is unknown, yet critical for understanding their function and potential clinical utility. Here we use quantitative proteomics to identify aminopeptidase P (APP) concentrated in caveolae of lung endothelium. Electron microscopy confirms this and shows that APP antibody targets nanoparticles to caveolae. Dynamic intravital fluorescence microscopy reveals that targeted caveolae operate effectively as pumps, moving antibody within seconds from blood across endothelium into lung tissue, even against a concentration gradient. This active transcytosis requires normal caveolin-1 expression. Whole body gamma-scintigraphic imaging shows rapid, specific delivery into lung well beyond that achieved by standard vascular targeting. This caveolar trafficking in vivo may underscore a key physiological mechanism for selective transvascular exchange and may provide an enhanced delivery system for imaging agents, drugs, gene-therapy vectors and nanomedicines. 'In vivo proteomic imaging' as described here integrates organellar proteomics with multiple imaging techniques to identify an accessible target space that includes the transvascular pumping space of the caveola.
引用
收藏
页码:327 / 337
页数:11
相关论文
共 54 条
  • [1] ALGER GH, 1943, J NATL CANCER I, V4, P1
  • [2] Bilbao G, 1998, ADV EXP MED BIOL, V451, P365
  • [3] ENDOTHELIAL PLASMALEMMAL VESICLES AS ELEMENTS IN A SYSTEM OF BRANCHING INVAGINATIONS FROM THE CELL-SURFACE
    BUNDGAARD, M
    FROKJAERJENSEN, J
    CRONE, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (12) : 6439 - 6442
  • [4] VASCULAR TARGETING - A NEW APPROACH TO THE THERAPY OF SOLID TUMORS
    BURROWS, FJ
    THORPE, PE
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (01) : 155 - 174
  • [5] Carver LA, 2002, BIOMEDICAL ASPECTS OF DRUG TARGETING, P107
  • [6] Caveolae: Mining little caves for new cancer targets
    Carver, LA
    Schnitzer, JE
    [J]. NATURE REVIEWS CANCER, 2003, 3 (08) : 571 - 581
  • [7] Proteomics in diagnostic pathology - Profiling and imaging proteins directly in tissue sections
    Chaurand, P
    Sanders, ME
    Jensen, RA
    Caprioli, RM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) : 1057 - 1068
  • [8] Pulmonary drug delivery systems: Recent developments and prospects
    Courrier, HM
    Butz, N
    Vandamme, TF
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (4-5): : 425 - 498
  • [9] DENEKAMP J, 1984, PROG APPLIED MICROCI, V4, P28
  • [10] Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
    Drab, M
    Verkade, P
    Elger, M
    Kasper, M
    Lohn, M
    Lauterbach, B
    Menne, J
    Lindschau, C
    Mende, F
    Luft, FC
    Schedl, A
    Haller, H
    Kurzchalia, TV
    [J]. SCIENCE, 2001, 293 (5539) : 2449 - 2452